SCHEMBL3309285

SCHEMBL3309285

O=C(O)C(O)=CC(=O)c1ccsc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LCK P06239 1/20 0.55
FYN P06241 1/20 0.55
DAO P14920 1/20 0.55
CES2 O00748 1/20 0.52
CES1 P23141 1/20 0.52
GPR52 Q9Y2T5 1/20 0.46
HDAC1 Q13547 1/20 0.46
HPGD P15428 1/20 0.43
HSD11B1 P28845 1/20 0.42
ALDH1A1 P00352 2/20 0.38
GAA P10253 2/20 0.38
ALOX12 P18054 2/20 0.38
KCNK3 O14649 1/20 0.38
KCNK9 Q9NPC2 1/20 0.38
HTT P42858 1/20 0.38
KDR P35968 3/20 0.38
NFE2L2 Q16236 1/20 0.35
NPC1 O15118 1/20 0.35
RAB9A P51151 1/20 0.35
MEN1 O00255 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3309282 1.00 LCK (0.55) LCKFYNDAOCES2CES1
SCHEMBL3309279 1.00 LCK (0.55) LCKFYNDAOCES2CES1
SCHEMBL3310255 0.81 LCK (0.47) LCKFYNDAOCES2CES1
SCHEMBL3310260 0.81 LCK (0.47) LCKFYNDAOCES2CES1
SCHEMBL10810400 0.76 CES2 (0.50) LCKFYNDAOCES2CES1
SCHEMBL9848078 0.76 MEN1 (0.56) LCKFYNDAOCES2CES1
SCHEMBL10810404 0.76 CES2 (0.50) LCKFYNDAOCES2CES1
SCHEMBL7493836 0.75
SCHEMBL24185398 0.74 LCK (0.47) LCKFYNDAOCES2CES1
SCHEMBL6050171 0.74

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20140171444-A1 Inhibitors of Mycobacterium Tuberculosis Malate Synthase, Methods of Making and Uses Thereof THE TEXAS A&M UNIVERSITY SYSTEM (US) 2014-06-19 US claimed
US-9737522-B2 NMDA receptor modulators and uses related thereto EMORY UNIVERSITY (US) 2017-08-22 US disclosed
US-20150196540-A1 NMDA RECEPTOR MODULATORS AND USES RELATED THERETO EMORY UNIVERSITY (US) 2015-07-16 US disclosed
US-20140171444-A1 Inhibitors of Mycobacterium Tuberculosis Malate Synthase, Methods of Making and Uses Thereof THE TEXAS A&M UNIVERSITY SYSTEM (US) 2014-06-19 US disclosed
US-8664255-B2 Inhibitors of mycobacterium tuberculosis malate synthase, methods of making and uses thereof THE TEXAS A&M UNIVERSITY SYSTEM (US) 2014-03-04 US disclosed
WO-2014025942-A1 NMDA RECEPTOR MODULATORS AND USES RELATED THERETO EMORY UNIVERSITY (US) 2014-02-13 WO disclosed
US-20100113477-A1 Inhibitors of mycobacterium tuberculosis malate synthase, methods of making and uses thereof TEXAS A&M UNIVERSITY SYSTEM, THE 2010-05-06 US disclosed
WO-2010047774-A2 INHIBITORS OF MYCOBACTERIUM TUBERCULOSIS MALATE SYNTHASE, METHODS OF MARKING AND USES THEREOF THE TEXAS A & M UNIVERSITY SYSTEM (US) 2010-04-29 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100113477-A1 Inhibitors of mycobacterium tuberculosis malate synthase, methods of making and uses thereof ME3, ME1, MDH1 LCK 1743/4885FYN 3820/4885DAO 39/4885
US-20150196540-A1 NMDA RECEPTOR MODULATORS AND USES RELATED THERETO GRIN2C, GRIN2A, GRIN3A LCK 598/4885FYN 786/4885DAO 304/4885
US-20140171444-A1 Inhibitors of Mycobacterium Tuberculosis Malate Synthase, Methods of Making and Uses Thereof ME3, ME1, MDH1 LCK 1743/4885FYN 3820/4885DAO 39/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.